Loutet MG, Zhang J, Varsaneux O, Ferguson A, Hulme J, Stone S, Oldenburger D, Piggott T. (2020). Using Experiential Simulation-Based Learning to Increase Engagement in Global Health Education: an Evaluation of Self-reported Participant Experience. Medical Science Educator. 30, 1245-1253. doi:10.1007/s40670-020-00999-w
Lexchin J. Would pharmacare spell trouble for drug companies? Canadian Centre for Policy Alternatives, August 5, 2020. View article here: http://behindthenumbers.ca/2020/08/05/would-pharmacare-spell-trouble-for-drug-companies/ [behindthenumbers.ca]
Kim D, Jelic T, Woo M, Heslop C, Olszynski P. (2020). Just the Facts: Recommendations on point-of-care ultrasound use and machine infection control during the coronavirus disease 2019 pandemic. CJEM, 22(4), 445-449. doi:10.1017/cem.2020.364
Hoyeck P, Wiercigroch D, Clarke C, Moineddin R, Sheikh H, Hulme J. (2020). Understanding current practice of opioid use disorder management in emergency departments across Canada: A cross-sectional study. CJEM, 22(4), 494-498. doi:10.1017/cem.2020.362
McLaren J, Hayman K, Sheikh H. (2020). CAEP Position Statement – Sick notes for minor illness. CJEM, 22(4), 475-476. doi:10.1017/cem.2020.53
Tawadrous D, Doran S, Davis M. (2020). Use of a smartphone plant identification application in a toxic plant ingestion. CJEM, 22(4), 549-551. doi:10.1017/cem.2020.30
Perry LT, Bhasale A, Fabbri A, Lexchin J, Puil L, Joarder M, Mintzes, B. A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016. Pharmacoepidemiology and Drug Safety 2020. doi:10.1002/pds.5072
Jarvis J, Lexchin J. WHO’s COVID-19 technology access pool deserves Canada’s support. Policy Options July 14, 2020. Available at: https://policyoptions.irpp.org/magazines/july-2020/whos-covid-19-technology-access-pool-deserves-canadas-support/
Lexchin J. COVID-19: still much to learn. Journal of the Royal Society of Medicine 2020;113(7):244. doi: 10.1177/0141076820932878
Wright JK, Tan DH, Walmsley SL, Hulme J, O’Connor E, Snider C, Cheng I, Chan AK, Borgundvaag B, McLeod S, Gollob MH, Clarke RJ, Dresser L, Haji F, Mazzulli T, Mubareka S, Jüni P, Lee D, Tomlinson G, Kain K, Landes, M. (2020). Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada. Trials, 21(1), 1-3. doi:10.1186/s13063-020-04577-8
Dharamsi A, Hayman K, Yi S, Chow R, Yee C, Gaylord E, Tawadrous D, Chartier LB, Landes M. (2020). Enhancing departmental preparedness for COVID-19 using rapid cycle in situ simulation. Journal of Hospital Infection. 105(4), 604-607. doi: 10.1016/j.jhin.2020.06.020.
Dion D, Mosleh-Shirazi, Lexchin J. Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study. BMJ Open 2020;10:e034993. doi:10.1136/ bmjopen-2019-034993.
Bhayana R, Wang CD, Menezes RJ, Bartlett ES, Choi J. (2020). Optimising after-hours workflow of computed tomography orders in the emergency department. BMJ open quality, 9(3), e000969.
Hansen K, Boyle A, Holroyd B, Phillips G, Benger J, Chartier LB, Lecky F, Vaillancourt S, Cameron P, Waligora G, Kurland L, Truesdale M, on behalf of the IFEM Quality and Safety Special Interest Group (2020). Updated framework on quality and safety in emergency medicine. Emergency Medicine Journal 2020;37:437-442.
Friedman N, Scolnik D, McMurray L, Bryan J. (2020). Acquired methemoglobinemia presenting to the pediatric emergency department: a clinical challenge. Canadian Journal of Emergency Medicine, 1-5.
Barth D, Nemec RM, Cho DD, Slomer A, Cojocari E, Kim K, McLean L, Patriquin CJ. (2020). The practical integration of a hybrid model of ultrasound‐guided peripheral venous access in a large apheresis center. Journal of Clinical Apheresis.
Lexchin J. (2020). "As U.S. buys up remdesivir, ‘vaccine nationalism’ threatens access to COVID-19 treatments". https://theconversation.com/as-u-s-buys-up-remdesivir-vaccine-nationalism-threatens-access-to-covid-19-treatments-141952
Moynihan R, Albarqouni L, Nangla C, Dunn AG, Lexchin J, Bero L. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ, 2020; 369:m1505. https://doi.org/10.1136/bmj.m1505
Lexchin J. Key opinion leaders and the control of knowledge. In: Allen DM, Howell JWeds. Groupthink in science: greed, pathological altruism, ideology, competition, and culture. Springer, 2020; 143-152.
James R, Lexchin J. After COVID-19’s tragic roll, Canada must improve quality of life in long-term care homes. The Conversation. June 7, 2020. Available at: https://theconversation.com/after-covid-19s-tragic-toll-canada-must-improve-quality-of-life-in-long-term-care-homes-139763
Elder K, Turner KA, Cosgrove L, Lexchin J, Shnier A, Moore A, Straus S, Thombs BD. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study. CMAJ, 2020; 192:E617-E625. doi:https://doi.org/10.1503/cmaj.191737
Sanford S, Schwartz B, Khan Y. The role of tacit knowledge in communication and decision-making during emerging public health incidents. International Journal of Disaster Risk Reduction, 2020; 101681. doi:https://doi.org/10.1016/j.ijdrr.2020.101681
Aubry T, Bloch G, Brcic V, Saad A, Magwood O, Abdalla T, Alkhateeb Q, Xie E, Mathew C, Hannigan T, Costello C, Thavorn K, Stergiopoulos V, Tugwell P, Pottie E. Effectiveness of permanent supportive housing and income assistance interventions for homeless individuals in high-income countries: a systematic review. The Lancet Public Health, 2020; 5(6): e342-e360. doi:https://doi.org/10.1016/S2468-2667(20)30055-4
Lexchin J. Drug Promotion in India Since 2000: Problems Remain. International Journal of Health Services, 2020; doi:https://doi.org/10.1177/0020731420932109
Lexchin J. Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort Study. International Journal of Health Policy and Management, 2020; doi:10.34172/ijhpm.2020.100
Lexchin J. Health Canada's Proposal to Accelerate New Drug Reviews. Healthcare Policy, 2020; 15(4), 26-34. doi:10.12927/hcpol.2020.26227
Friedman SM, Porplycia D. STAR-EM: An innovative summer research program for medical students. CJEM, 2020; 1-4. doi:10.1017/cem.2020.366
Wiercigroch D, Ben-Yakov M, Friedman SM. Regional anesthesia in Canadian emergency departments: emergency physician practices, perspectives and barriers to use. CJEM, 2020; 1-5. doi:10.1017/cem.2020.51
Turner K, Carboni-Jiménez A, Benea C, Katharine E, Levis B, Boruff J, Roseman M, Bero L, Lexchin J, Turner EH, Benedetti A, Thombs BD. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study. BMJ Open, 2020; 10(5), e035633. doi:10.1136/bmjopen-2019-035633
Woolner V, Ahluwalia R, Lum H, Beane K, Avelino J, Chartier LB. Improving timely analgesia administration for musculoskeletal pain in the emergency department. BMJ Open Quality, 2020; 9(1), e000797. doi:10.1136/bmjoq-2019-000797
Ostrow O, Shim A, Azmat S, Zelinka A, Masood S, Chartier, LB. Pediatric Emergency Department Return Visits: An Innovative and Systematic Approach to Promote Quality Improvement and Patient Safety. Pediatr Emerg Care, 2020; [Epub ahead of print]. PMID: 31977769. doi:10.1097/PEC.0000000000001999
Thull-Freedman, J, Mondoux, S, Stang, A, Chartier LB. Going to the COVID-19 Gemba: Using observation and high reliability strategies to achieve safety in a time of crisis. CJEM, 2020; 1-4. doi:10.1017/cem.2020.380
Mondoux S, Thull-Freedman J, Dowling S, Gardner K, Taher A, Gupta R, Trivedi S, Lindsay H, Finlayson A, Berthelot S, Kwok E, Chartier LB. Quality improvement in the time of COVID-19 – a change strategy well suited to pandemic response. CJEM, 2020; 1-4. doi:10.1017/cem.2020.386
Nolan B, Chartier LB, Verbeek P, Huyer D, Mazurik L. Recommendations for emergency departments receiving patients with vital signs absent from paramedics during COVID-19. CJEM, 2020; 1-5. doi:10.1017/cem.2020.389
Lexchin J. Affordable Biologics for All. JAMA Netw Open. 2020;3(4):e204753. doi:10.1001/jamanetworkopen.2020.4753
Hendin A, La Rivière, CG, Williscroft DM, O'Connor E, Hughes J, Fischer LM. End-of-life care in the Emergency Department for the patient imminently dying of a highly transmissible acute respiratory infection (such as COVID-19). CJEM, 2020; 1-5. doi:10.1017/cem.2020.352
Lexchin J, Rasmussen N. The rise and fall of the neurotic housewife: patient sex in psychotropic drug advertising to physicians 1946-1990. International Journal of Health Services 2020: DOI: 10.1177/0020731420912999
Benea C, Turner KA, Roseman M, Bero LA, Lexchin J, Turner EH, Thombs BD. Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009. Systematic Reviews 2020;9:77
Hobday K, Zwi AB, Homer C, Kirkham R, Hulme J, Wate PZ, Prata N. Misoprostol for the prevention of post-partum haemorrhage in Mozambique: an analysis of the interface between human rights, maternal health and development. BMC International Health and Human Rights. 2020; 20(1):1-3.
Lexchin J, Mintzes B. Opioid marketing to Canadian doctors hyped benefits, downplayed harms. The Conversation. March 10, 2020. Available at: https://theconversation.com/opioid-marketing-to-canadian-doctors-hyped-benefits-downplayed-harms-132732
Lexchin J. Canada’s coronavirus aid package guards against drug shortages with compulsory licensing. The Conversation. March 30, 2020. Available at: https://theconversation.com/canadas-coronavirus-aid-package-guards-against-drug-shortages-with-compulsory-licensing-134974
Sheikh H, Sunstein CR. Respecting autonomy: "Information first, then opinion" is more effective than "opinion first, then information". Journal of Behavioral Economics for Policy, 2019;3(2), 5-10. Available here: https://sabeconomics.org/documents/respecting-autonomy-information-first-then-opinion-is-more-effective-than-opinion-first-then-information/
Mintzes B, Fabbri A, Grundy Q, Spurling GKP, Lexchin J, McKenzie JE, Bero L. Information and promotional strategies by pharmaceutical companies for clinicians. Cochrane Database of Systematic Reviews 2019, Issue 9. Art. No.: CD013423. DOI: 10.1002/14651858.CD013423.
Sheikh H. CAEP Position Statement on Dental Care in Canada.
McDonald M, Lavelle C, Wen M, Sherbino J, Hulme J. The state of health advocacy training in postgraduate medical education: a scoping review. Medical Education 2019. doi: 10.1111/medu.13929.
Kumar T, Sheikh H. CAEP Statement Re: Universal Pharmacare. September 5, 2019.
Lexchin J. Re: should national pharmacare apply a value-based insurance design. CMAJ 2019.
Collier A, Marton G, Chun S, Nijssen-Jordan C, Bartels SA, Pulfrey S, Lang E, Schull M, Landes M, Johnson K. CAEP 2018 Academic Symposium: Recommendations for developing and supporting Global Emergency Medicine in Canadian academic emergency departments and divisions. CJEM 2019;21(5):600–606.
Lexchin J. Leave the patchwork for the quilts: the case for pharmacare. The Conversation. August 25, 2019.
Lexchin J. Health Canada and big pharma: too close for comfort. The Conversation. July 12, 2019.
Puchalski Ritchie LM, van Lettow M, Pham B, et al. What interventions are effective in improving uptake and retention of HIV-positive pregnant and breastfeeding women and their infants in prevention of mother to child transmission care programmes in low-income and middle-income countries? A systematic review and meta-analysis. BMJ Open 2019;9:e024907. doi:10.1136/ bmjopen-2018-024907
Lexchin J. Choosing Wisely Canada needs to start helping doctors to understand how commercial influences affect their prescribing. Healthcare Papers 2019;18(1):30-34
Lexchin J. Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study. BMJ Open 2019;9:e030750. doi:10.1136/ bmjopen-2019-030750
Gorfinkel I, Lexchin J. Enabling patient portals to access primary care medical records: maximizing collaboration in care between patients and providers. Healthcare Policy 2019;14(4):21-27
Elfassy, MD, Danho S, Adibfar A, Lexchin J. Direct-to-consumer advertising of prescription medications: what the Canadian medical trainee needs to know. Canadian Medical Education Journal 2019;10(3):E113-E116
Thindwa D, Landes M, Lettow Mv, Kanyemba A, Nkhoma E, Phiri H, et al. (2019) Pregnancy intention and contraceptive use among HIV-positive Malawian women at 4-26 weeks postpartum: A nested cross-sectional study. PLoS ONE 14(4): e0215947. https://doi.org/10.1371/journal.pone.0215947
Lexchin J, Menkes DB. Can direct-to-consumer advertising of prescription drugs be effectively regulated? New Zealand Journal of Medicine 2019;132:59-65.
Landes M, van Lettow M, Nkhoma E, Tippett Barr B, Truwah Z, Shouten E, Jahn A, Auld A, Kalua T, van Oosterhout J. Low detectable postpartum viral load is associated with HIV transmission in Malawi’s prevention of mother-to-child transmission programme (2019) Journal of the International AIDS Society, 22:e25290.
Landes M, Pfaff C, Zerihun M, Wondimagegn, SodhiS, Rouleau K, Kidd M. Calling non-governmental organisations to strengthen primary health care: Lessons following Alma-Ata. (2019) African Journal of Primary Health Care & Family MedicineISSN: (Online) 2071-2936, (Print) 2071-2928
Kwok, E., Perry, J., Mondoux, S., & Chartier, L. An environmental scan of quality improvement and patient safety activities in emergency medicine in Canada. CJEM, 1-7. doi:10.1017/cem.2019.16
Khan Y, Tracey S, O’Sullivan T, Gournis E, Johnson I. Retiring the Flip Phones: Exploring Social Media Use for Managing Public Health Incidents. Disaster Med Public Health Prep. 2019 Jun 20:1-9. doi: 10.1017/dmp.2018.147. [Epub ahead of print]
Chartier, L., Mondoux, S., Stang, A. et al. How do emergency departments and emergency leaders catalyze positive change through quality improvement collaborations? CJEM, 1-8. doi:10.1017/cem.2019.25
Braillon A, Lexchin J. Innovation and off-label use, the French case and more. British Journal of Clinical Pharmacology 2019.
Lexchin J. Declarations of interest by members of Health Canada’s
special advisory committees and panels: a descriptive study. CMAJ OPEN. 2019;7(2).
Lexchin J. Pharmaceutical Industry-Initiated Postapproval Studies- Not Requested by the US FDA, Little Value, and Many Questions. JAMA Network Open. 2019;2(5):e193392.
Puchalski Ritchie L, Debebe F, Azazh A. Barriers to and facilitators of the development and utilization of context appropriate evidence based clinical algorithms to optimize clinical care and patient outcomes in the Tikur Anbessa emergency department: a multi-component qualitative study. BMC Health Services Research. 2019 19:181.
Lexchin J. Increase in drug spending in Canada due to extension of data protection for biologics: a descriptive study. Healthcare Policy 2019;14(3):10-18.
Lexchin J, Herder M, Doshi P. Canada finally opens up data on new drugs and devices: Other regulators should take note of Health Canada’s substantive reforms. BMJ 2019;365:l1825 doi: 10.1136/bmj.l1825
Bryan J. Trust me, I'm a doctor: Public trust in the Information Age. CMAJ. Published on: 14 April 2019.
Braillon A, Lexchin J, Blumsohn A, Hengartner MP. Pharmaceuticalisation of life. BMJ. Posted on-line April 10, 2019.
Lexchin J. RE: New CMAJ policy on competing interests in guidelines. Published on-line April 3, 2019.
Groot E, Caturay A, Khan Y, Copes R. A systematic review of the health impacts of occupational exposure to wildland fires. International Journal of Occupational Medicine and Environmental Health 2019;32(2):121 – 140
Torka M, Mintzes B, Bhasale A, Fabbri A, Perry L, Lexchin J. Secret safety warnings on medicines: a case study of information access requests. Pharmacoepidemiology and Drug Safety 2019;DOI: 10.1002/pds.4762
Lexchin J. Federal budget: A Canadian Drug Agency and rare disease funding are not enough. The Conversation. March 20, 2019.
Lexchin J. Association between commercial funding of Canadian patient groups and their views about funding of medicines: an observational study. PLoS One 2019;14:e0212399.
Lexchin J. How Big Pharma’s free samples encourage your doctor to prescribe more expensive drugs. The Conversation. February 10, 2019.
Lee DS, Lee JS, Schull MJ, Borgundvaag B, Edmonds ML, Ivankovic M, McLeod SL, Dreyer JF, Sabbah S, Levy PD, O’Neill T, Chong A, Stukel TA, Austin PC, Tu JV. Prospective Validation of the Emergency Heart Failure Mortality Risk Grade for Acute Heart Failure. Circulation. 2019;139:1146–1156.
Laytin Ad, Azazh A, Girma B, Debebe F, Beza L, Seid H, Landes M, Wytsma J, Reynolds TA. Mixed methods process evaluation of pilot implementation of the African Federation for Emergency Medicine trauma data project protocol in Ethiopia. 2019 African Journal of Emergency Medicine, https://doi.org/10.1016/j.afjem.2019.01.009
Bavli I, Lexchin J. Why Big Pharma must dislocse payments to patient groups. The Conversation. January 14, 2019.
Ågotnes G, McGregor MJ, Lexchin J, Doupe MB, Müller B, Harrington C. An international mapping of medical care in nursing homes. Health Services Insights 2019;12:1-12
O’Brien T, Ivers N, Bhattacharyya O, Calzavara A, Pus L, Mukerji G, Friedman SM, Abrams H, Stanaitis I, Hawker GA, Pariser P. A multifaceted primary care practice-based intervention to reduce ED visits and hospitalization for complex medical patients: A mixed methods study. PLoS ONE. 2019; 14(1): e0209241. doi.org/10.1371/journal.pone.0209241
Delaigue S, Bonnardot L, Steichen O, Garcia DM, Venugopal R, Saint-Sauveur JF, Wootton R. Seven years of telemedicine in Médecins Sans Frontières demonstrate that offering direct specialist expertise in the frontline brings clinical and educational value. J Glob Health. 2018 Dec;8(2):020414.
Lexchin J. Health Canada’s use of its Notice of Compliance with Conditions drug approval policy: a retrospective cohort analysis. International Journal of Health Services 2018.